American Journal of Cardiology
Volume 104, Issue 1 , Pages 36-40 , 1 July 2009

Timing and Duration of Myocardial Ischemia on Holter Monitoring Following Percutaneous Coronary Intervention and Their Association With Clinical Outcomes (a PROTECT-TIMI 30 Substudy Analysis)

  • C. Michael Gibson, MS, MD

      Affiliations

    • TIMI Study Group, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: 617-525-6884; fax: 888-249-5261
    • ,
  • Yuri B. Pride, MD

      Affiliations

    • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Jacqueline L. Buros, BS

      Affiliations

    • TIMI Study Group, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • Lauren N. Ciaglo, BA

      Affiliations

    • TIMI Study Group, Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
    • ,
  • David A. Morrow, MD

      Affiliations

    • TIMI Study Group, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Benjamin M. Scirica, MD

      Affiliations

    • TIMI Study Group, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • Peter H. Stone, MD

      Affiliations

    • Division of Cardiovascular Medicine, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts
    • ,
  • TIMI Study Group

Received 31 December 2008 ,Revised 20 February 2009 ,Accepted 20 February 2009.

References 

  1. Gibson CM, Morrow DA, Murphy SA, Palabrica TM, Jennings LK, Stone PH, et al. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. J Am Coll Cardiol. 2006;47:2364–2373
  2. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284:835–842
  3. Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002;105:1909–1913
  4. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101:125–130
  5. Akkerhuis KM, Klootwijk PA, Lindeboom W, Umans VA, Meij S, Kint PP, et al. Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients. Eur Heart J. 2001;22:1997–2006
  6. Goodman SG, Barr A, Sobtchouk A, Cohen M, Fromell GJ, Laperriere L, et al. Low molecular weight heparin decreases rebound ischemia in unstable angina or non–Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy. J Am Coll Cardiol. 2000;36:1507–1513
  7. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med. 1986;314:1214–1219
  8. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol. 1987;10:756–760
  9. Johnson SM, Mauritson DR, Winniford MD, Willerson JT, Firth BG, Cary JR, et al. Continuous electrocardiographic monitoring in patients with unstable angina pectoris: identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am Heart J. 1982;103:4–12
  10. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol. 1989;13:1495–1502
  11. Nademanee K, Intarachot V, Josephson MA, Rieders D, Vaghaiwalla Mody F, Singh BN. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol. 1987;10:1–9
  12. Patel DJ, Holdright DR, Knight CJ, Mulcahy D, Thakrar B, Wright C, et al. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart. 1996;75:222–228
  13. Patel DJ, Knight CJ, Holdright DR, Mulcahy D, Clarke D, Wright C, et al. Long-term prognosis in unstable angina (The importance of early risk stratification using continuous ST segment monitoring). Eur Heart J. 1998;19:240–249
  14. Pozzati A, Bugiardini R, Borghi A, Ottani F, Muzi A, Morgagni G, et al. Transient ischaemia refractory to conventional medical treatment in unstable angina: angiographic correlates and prognostic implications. Eur Heart J. 1992;13:360–365
  15. Zairis MN, Manousakis SJ, Adamopoulou EN, Makrygiannis SS, Glyptis MP, Beldekos DJ, et al. Continuous 12-lead electrocardiographic ST monitoring and long-term prognosis after successful coronary stenting. Am Heart J. 2006;151:892–897
  16. Zairis MN, Lyras AG, Makrygiannis SS, Beldekos DJ, Mainas KA, Patsourakos NG, et al. Continuous 12-lead electrocardiographic ST monitoring adds prognostic information to the thrombolysis in myocardial infarction risk score in patients with non–ST-elevation acute coronary syndromes. Clin Cardiol. 2005;28:189–192
  17. Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation. 2007;115:1895–1903
  18. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol. 2004;44:1103–1110
  19. Dumont EA, Hofstra L, van Heerde WL, van den Eijnde S, Doevendans PA, DeMuinck E, et al. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation. 2000;102:1564–1568

 This word was supported in part by grants from Millennium Pharmaceuticals, Cambridge, Massachusetts, and Schering-Plough Research Institute, Kennilworth, New Jersey.

PII: S0002-9149(09)00664-X

doi: 10.1016/j.amjcard.2009.02.044

American Journal of Cardiology
Volume 104, Issue 1 , Pages 36-40 , 1 July 2009

Article Tools

* Image Usage & Resolution